Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
BioProduction 2008

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 24 October 2003:
Vol. 302. no. 5645, pp. 597 - 599
DOI: 10.1126/science.1089864
Prev | Table of Contents | Next

Viewpoint

Genomics and Global Health: Time for a Reappraisal

David J. Weatherall

Although currently there are only a limited number of genomic technologies that are applicable to health care in the developing countries, this is unlikely to be the case in the near future. If, however, the full potential of genomics for health care is to be fulfilled, there will have to be a complete change of emphasis in education and research in the richer countries toward a more global view of disease and its consequences.

Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK.

E-mail: david.weatherall{at}imm.ox.ac.uk

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe.
I. Roberts and M. de Montalembert (2007)
Haematologica 92, 865-871
   Full Text »    PDF »
A case for developing North-South partnerships for research in sickle cell disease.
D. Weatherall, K. Hofman, G. Rodgers, J. Ruffin, and S. Hrynkow (2005)
Blood 105, 921-923
   Abstract »    Full Text »    PDF »
A New Year's resolution after a lost decade.
D J Weatherall (2003)
BMJ 327, 1415-1416
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)